AstriVax logo

AstriVax jobs and careers

Heverlee, Flemish Region, Belgium

About AstriVax

AstriVax is a privately held spin-off company from the KU Leuven, founded in 2022 based on vaccine technology developed at the Rega Institute. AstriVax is building a first in class Plug & Play vaccine platform with a patented DNA based technology that launches self-amplifying live attenuated viruses. The versatile technology of AstriVax can be used to develop a wide range of vaccines to prevent and treat infectious diseases. AstriVax aims to address major challenges in vaccinology by developing novel vaccines that are easy to produce, have reduced cold chain requirements, and offer broad and long-lasting protection against various viruses and other pathogens.

Employees
1 to 10
Headquarters
Heverlee

Leadership

The top of AstriVax's org chart, with how many people report into each leader.

HC

Hanne Callewaert

Chief Executive Officer

15 reports

WD

Wilfried Dalemans

Chief Technical Officer (ad Interim)

6 reports

SO

Sophie Olivier

CMO a.i.

2 reports

MPPhoto of Mathieu Peeters

Mathieu Peeters

Chief Development Officer (CDO)

1 report

AH

An Huysmans

Finance Lead

ID

Isabelle Decoster

HR Lead

GF

Greg Fanning

Chief Business Officer

Board

PP

Peter Piot

Scientific Advisory Board Member

SM

Shelley Margetson

Board Member

JV

Jeroen Vangindertael

Board Observer

CB

Christian Brander

Scientific Advisory Board Member

BT

Bart De Taeye

Board Member

JB

Jeanne Bolger

Chairman & Independent Board Member